Monthly Archives: March 2010

Judge Spikes Myriad Genetic’s Control of Genes

Image via Wikipedia Score one for nature. A US district court judge on Monday declared that pharma companies can’t patent individual genes because they are they are not, in fact, creating them. Last spring, Myriad Genetics was taken to task by the ACLU for monopolizing a patent it had discovered for breast cancer. The civil […]
Posted in Biotech, News | Tagged , , , , , , , | 1 Comment

Pharma Cheers Health Reform Legislation

Image by SEIU International via Flickr After months of increasingly rancorous debate, the House finally approved legislation March 21 that makes significant changes in the nation’s health care system. The Senate is slated to approve the House-passed changes to its original reform bill shortly. Of most importance to pharmaceutical companies, the legislation promises to significantly […]
Posted in News | Tagged , , , , , , , | 3 Comments

Parallel Importers Framed in Europe

Guest blog by Pharmaceutical Executive Europe‘s Brussels correspondent, Reflector. The European debate about combating counterfeit medicines is generating a lot of heat in Brussels as it comes to a head. This month the European Parliament is starting to tackle the detail of the European Commission’s proposal to stop falsified products getting into the legal supply […]
Posted in Strategy | Leave a comment

Tauzin’s Farewell to PhRMA

Image via Wikipedia In an emotional farewell address to PhRMA, President Billy Tauzin recapped his five years at the helm of the organization and his efforts to “recapture the value of the PhRMA brand” and to “re-earn the trust of people who had lost faith in us.” “We had to take the target off our […]
Posted in People, Regulatory | Tagged , , , , , , , | 1 Comment

A Critical Path to New TB Treatments

Image via Wikipedia FDA Commissioner Margaret Hamburg announced, on Thursday, a new joint initiative between industry, FDA, and non-profit organizations designed to fast-track modern combination treatments for tuberculosis. Where once it took more than two decades to create new therapies for TB, this collaboration is expected to produce working treatments in less than six years, […]
Posted in R&D | Tagged , , , , , , , | 2 Comments
  • Categories

  • Meta